PRESS & NEWS
The Promise of FTD Research Trials: A Webinar on December 7, 2022
Perspectives in FTD Research Webinar Series
Perspectives in FTD Research Webinar Series
Industry trials for genetic FTD are generating optimism for potential treatments for all types of FTD.
Current clinical trials will be the subject of the webinar, “The Promise of FTD Research Trials: What should I know about current drug studies?” on Wednesday, December 7, 2022, beginning at 3:00 p.m. ET (12:00 p.m. Pacific). This webinar is part of the Perspectives in Research Webinar Series co-hosted by the Association for Frontotemporal Degeneration and the FTD Disorders Registry.
Dianna Wheaton, Ph.D., Director of the FTD Registry, will highlight the principles of research, explain the different types of research, and touch on the genetic aspects that influence research.
Laura Mitic, Ph.D., Chief Scientific Officer for the Bluefield Project to Cure FTD, will start with an overview of what clinical trials are before delving into the details of specific studies. She also will cover what to think about and questions to ask when you are considering whether to volunteer for research.
During this hour, you can expect to:
The webinar will be about 60 minutes long. You must register to attend.
Watch the replay:
PRESENTERS
Dr. Laura Mitic manages Bluefield’s efforts to translate scientific discoveries into therapeutics. She works closely with scientists in the Bluefield Research Consortium to identify and accelerate promising ideas and leads efforts to support the development of biomarkers and clinical endpoints for FTD. She meets regularly with academic and industry scientists to enable collaborative projects and oversees Bluefield’s communication strategy.
Dr. Mitic earned an undergraduate degree in biology from Northwestern University and a Ph.D. in cell biology from Yale University. After completing postdoctoral studies in the genetics of aging at the University of California, San Francisco, she joined the Consortium for FTD Research (CFR) in 2009 and helped to establish the Bluefield Project in 2011.
Dr. Dianna Wheaton joined the field of FTD research as Director of the FTD Disorders Registry in January 2016. She manages the daily operations of the Registry, working directly with persons diagnosed with FTD and their families, and leading outreach efforts to the lay and health professional communities. She assists clinicians, other researchers, and organizations interested in using the Registry to answer important research questions and to support clinical trials.
Dr. Wheaton earned her Master of Science degree in Biology (Genetic Counseling) from the University of North Texas and her Ph.D. in Health Studies (Community/Population Health) from Texas Woman’s University. She has more than 20 years of clinical science research experience and genetic counseling for patients and at-risk family members.
The Perspectives in FTD Research Webinar Series is designed to help FTD-diagnosed persons, care partners, family members, and persons at risk for developing FTD become informed FTD research participants.
Together we can find a cure for ftd
The FTD Disorders Registry is a powerful tool in the movement to create therapies and find a cure. Together we can help change the course of the disease and put an end to FTD.
Your privacy is important! We promise to protect it. We will not share your contact information.